Towards host-directed therapies for tuberculosis
Authors list
Alimuddin Zumla Jeremiah Chakaya Michael Hoelscher Francine Ntoumi Roxana Rustomjee Cristina Vilaplana Dorothy Yeboah-Manu Voahangy Rasolof Paula Munderi Nalini Singh Eleni Aklillu Nesri Padayatchi Eusebio Macete Nathan Kapata Modest Mulenga Gibson Kibiki Sayoki Mfinanga Thomas Nyirenda Leonard Maboko Alberto Garcia-Basteiro Niaina Rakotosamimanana Matthew Bates Peter Mwaba Klaus Reither Sebastien Gagneux Sarah Edwards Elirehema Mfinanga Salim Abdulla Pere-Joan Cardona James BW Russell Vanya Gant Mahdad Noursadeghi Paul Elkington Maryline Bonnet Clara Menendez Tandakha N Dieye Bassirou Diarra Almoustapha Maiga Abraham Aseffa Shreemanta Parida Christian Wejse Eskild Petersen Pontiano Kaleebu Matt Oliver Gill Craig Tumena Corrah Leopold Tientcheu Martin Antonio Martin Rao Timothy D McHugh Aziz Sheikh Giuseppe Ippolito Gita Ramjee Stefan HE Kaufmann Gavin Churchyard Andrie Steyn Martin Grobusch Ian Sanne Neil Martinson Rajhmun Madansein Robert Wilkinson Bongani Mayosi Marco Schito Robert S Wallis Markus Maeurer Toggle all authors (65)
Abstract
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.
Journal details
Journal Nature Reviews Drug Discovery
Volume 14
Issue number 8
Pages 511-512
Publication date
Full text links
Publisher website (DOI) 10.1038/nrd4696
Europe PubMed Central 26184493
Pubmed 26184493
Keywords
Related topics
Type of publication
